Enrollment on hold

The Association of Breast Density Changes, Plasma Hormone Changes, and Breast Cancer Recurrence: A Companion Study to NCIC CTG MA.27

NCT No.: NCT00316836

Study Type: Other Observational Study with Direct Patient Contact

Phase:

Region: California - Northern

Acronym: 

Official Title

The Association of Breast Density Changes, Plasma Hormone Changes, and Breast Cancer Recurrence: A Companion Study to NCIC CTG MA.27

Purpose

This clinical trial is studying the relationship between breast density and blood levels of hormones and anticancer drugs in women with invasive breast cancer who are receiving exemestane or anastrozole.

Detailed Description

Additional Principal Investigator for this trial: Tatjana Kolevska, Vallejo, CA.

Sex

Male & Female

Age Limit

Eligibility Criteria

Inclusion Criteria

  • Female Postmenopausal Agrees to retrieve and digitize mammograms taken prior to registration (within 12 months prior to atudy entry) and at approximately 1 and 2 years post-registration to this study Agrees to have an additional blood banking specimen drawn at the same time as pre-treatment specimens are drawn for parent protocol CAN-NCIC-MA27 Agrees to have blood sample taken at 12 months post-registration on this study

Exclusion Criteria

  • Less than 6 months of prior hormone replacement therapy, oral contraceptives, tamoxifen, raloxifene, and other selective estrogen-receptor modulators, or gonadotropin releasing-hormone analogues before pre-registration mammogram.

Keywords and/or Specific Medical Conditions

  • stage I breast cancer, stage II breast cancer, stage IIIA breast cancer,
  • Obstetrics and Gynecology
  • Oncology (Adult)

Sponsors

  • Alliance for Clinical Trials in Oncology

KP Clinical Facility

Clinical Area

  • Obstetrics and Gynecology
  • Oncology (Adult)

Principal Investigator

Harzstark Andrea  

Contact Information

 - CTP
- ctpcollaborate@kp.org
- All Kaiser Permanente Northern California Medical Centers

Find a study